Metabolic Syndrome in Androgenetic Alopecia in a Tertiary Care Center in Goa: A Case-Control Study During COVID-19 Pandemic

The study conducted in Goa during the COVID-19 pandemic found a significant association between androgenetic alopecia (AGA) and metabolic syndrome (MetS) in 54 patients with AGA compared to 54 controls. AGA patients had a higher prevalence of MetS (40.7% vs. 14.8% in controls), with significant differences in diastolic blood pressure, triglyceride levels, and fasting blood sugar levels. No significant differences were observed in systolic blood pressure, HDL levels, or waist circumference, nor between mild and severe AGA cases. The study suggests screening AGA patients for MetS components to prevent adverse outcomes, though the pandemic-limited sample size may have influenced results.